Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 18;11(5):1328.
doi: 10.3390/nano11051328.

Unveiling the Potential Role of Nanozymes in Combating the COVID-19 Outbreak

Affiliations

Unveiling the Potential Role of Nanozymes in Combating the COVID-19 Outbreak

Jafar Ali et al. Nanomaterials (Basel). .

Abstract

The current coronavirus disease 2019 (COVID-19) outbreak is considered as one of the biggest public health challenges and medical emergencies of the century. A global health emergency demands an urgent development of rapid diagnostic tools and advanced therapeutics for the mitigation of COVID-19. To cope with the current crisis, nanotechnology offers a number of approaches based on abundance and versatile functioning. Despite major developments in early diagnostics and control of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), there is still a need to find effective nanomaterials with low cost, high stability and easy use. Nanozymes are nanomaterials with innate enzyme-like characteristics and exhibit great potential for various biomedical applications such as disease diagnosis and anti-viral agents. Overall the potential and contribution of nanozymes in the fight against SARS-CoV-2 infection i.e., rapid detection, inhibition of the virus at various stages, and effective vaccine development strategies, is not fully explored. This paper discusses the utility and potential of nanozymes from the perspective of COVID-19. Moreover, future research directions and potential applications of nanozymes are highlighted to overcome the challenges related to early diagnosis and therapeutics development for the SARS-CoV-2. We anticipate the current perspective will play an effective role in the existing response to the COVID-19 crisis.

Keywords: SARS-CoV-2; coronavirus disease 2019 (COVID-19); diagnostics; nanozyme; vaccines.

PubMed Disclaimer

Conflict of interest statement

Authors declares the no conflict of interest.

Figures

Figure 1
Figure 1
Advantages of nanozyme and their potential applications in fight against coronavirus disease 2019 (COVID-19).
Figure 2
Figure 2
Possible mechanism of nanozyme-mediated sandwich enzyme-linked immunosorbent assay (ELISA) for SARS-CoV-2 detection.
Figure 3
Figure 3
Possible mechanism of virus inactivation: (A) by blocking the viral entry, (B) by inhibiting viral RNA synthesis, (C) by blocking viral assembly and proliferation.

Similar articles

Cited by

References

    1. Kilbourne E.D. Influenza pandemics of the 20th century. Emerg. Infect. Dis. 2006;12:9–14. doi: 10.3201/eid1201.051254. - DOI - PMC - PubMed
    1. Taubenberger J.K. The origin and virulence of the 1918 “Spanish” influenza virus. Proc. Am. Philos. Soc. 2006;150:86–112. - PMC - PubMed
    1. Greenberg M., Jacobziner H., Pakter J., Weisl B.A. Maternal mortality in the epidemic of Asian influenza, New York City, 1957. Am. J. Obstet. Gynecol. 1958;76:897–902. doi: 10.1016/0002-9378(58)90027-9. - DOI - PubMed
    1. Rajagopal S., Treanor J. Pandemic (avian) influenza. Semin. Respir. Crit. Care Med. 2007;28:159–170. doi: 10.1055/s-2007-976488. - DOI - PubMed
    1. Meng L., Hua F., Bian Z. Coronavirus Disease 2019 (COVID-19): Emerging and Future Challenges for Dental and Oral Medicine. J. Dent. Res. 2020;99:481–487. doi: 10.1177/0022034520914246. - DOI - PMC - PubMed

LinkOut - more resources